Dietary supplement with vitamin C prevents nitrate tolerance

Journal of Clinical Investigation

Volumn 102, Issue 1, 1998, Pages 67-71

  Bassenge, Eberhard ^a   Fink, Nelli ^a   Skatchkov, Mikhail ^a   Fink, Bruno ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Arterial conductivity; Cyclic guanylyl monophosphate; Membrane microviscosity; Platelet aggregation; Soluble guanylyl cyclase activity

Indexed keywords

ASCORBIC ACID; CYCLIC GMP; GLYCERYL TRINITRATE; NITRATE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; DIET SUPPLEMENTATION; DRUG TOLERANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; EVOKED RESPONSE; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MALE; MEDIATOR RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0032127952     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI977     Document Type: Article

References (40)

1. Abrams, J. 1992. Use of nitrates in ischemic heart disease. Curr. Probl. Cardiol. 17:481-542.
2. Rudolph, W., J. Dirschinger, F. Kraus, G. Reiniger, and D. Hall. 1990. Nitrate therapy in patients with coronary artery disease, preparations and doses with and without development of tolerance. Z. Kardiol. 79(Suppl. 3):57-65.
3. Münzel, T., A. Giaid, S. Kurz, D.J. Stewart, and D.G. Harrison. 1995. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc. Natl. Acad. Sci. USA. 92:5244-5248.
4. Münzel, T., H. Sayegh, B.A. Freeman, M.M. Tarpey, and D.G. Harrison. 1995. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J. Clin. Invest. 95:187-194.
5. Münzel, T., and E. Bassenge. 1996. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation. 93:2052-2058.
6. Rajagopalan, S., S. kurz, T. Munzel, M. Tarpey, B.A. Freeman, K.K. Griendling, and D.G. Harrison. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/ NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1416-1423.
7. Münzel, T., S. Kurz, S. Rajagopalan, M. Thoenes, W.R. Berrington, J.A. Thompson, B.A. Freeman, and D.G. Harrison. 1996. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J. Clin. Invest. 98:1465-1470.
8. 2-radical formation resulting from impaired NO-scavenging. Pfluegers Arch. 429:R108.
9. Bassenge, E., and B. Fink. 1996. Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:363-367.
10. Bassenge, E., and B. Fink. 1996. Suppression of nitrate induced tolerance by vitamin C and other antioxidants. In The Biology of Nitric Oxide, Part 5. S. Moncada, J. Stamler, S. Gross, and E.A. Higgs, editors. Portland Press Ltd., London. 198.
11. Münzel, T., J. Holtz, A. Mülsch, D.J. Stewart, and E. Bassenge. 1989. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist. Circulation. 79:188-197.
12. Skatchkov, M., B. Fink, S. Dikalov, O. Sommer, and E. Bassenge. 1996. Antioxidant mediated prevention of nitrate tolerance is achieved through immediate inactivation of peroxinitrite. In The Biology of Nitric Oxide: Part 5. S. Moncada, J. Stamler, S. Gross, and E.A. Higgs, editors. Portland Press Ltd. London. 199.
13. Ting, H.H., F.K. Timimi, K.S. Boles, S.J. Creager, P. Ganz, and M.A. Creager. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97:22-28.
14. Levine, G.N., B. Frei, S.N. Koulouris, M.D. Gerhard, J.F.J. Keaney, and J.A. Vita. 1996. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 93:1107-1113.
15. Solzbach, U., B. Hornig, M. Jeserich, and H. Just. 1997. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 96:1513-1519.
16. Ting, H.H., F.K. Timimi, E.A. Haley, M.A. Roddy, P. Ganz, and M.A. Creager. 1997. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:2617-2622.
17. Heitzer, T., H.J. Just, and T. Münzel. 1996. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 94:6-9.
18. Imhof, P.R., B. Ott, P. Frankhauser, L.C. Chu, and J. Hodler. 1980. Difference in nitroglycerin dose-response in the venous and arterial beds. Eur. J. Clin. Pharmacol. 18:455-460.
19. Buschmann, M., A. Wiegand, K. Schnellbacher, R. Bonn, A. Rehe, D. Trenk, E. Jähnchen, and H. Roskamm. 1993. Comparison of the effects of two different galenical preparations of glyceryl trinitrate on pulmonary artery pressure and on the finger pulse curve. Eur. J. Clin. Pharmacol. 44:451-456.
20. Pachla, L.A., and P.T. Kissinger. 1979. Analysis of ascorbic acid by liquid chromatography with amperometric detection. Methods Enzymol. 62:15-24.
21. 2+ and on aggregation of human platelets. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 244:37-47.
22. Grynkiewicz, G., M. Poenie, and R.Y. Tsien. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
23. Feijge, M.A.H., J.W.M. Heemskerk, and G. Hornstra. 1990. Membrane fluidity of non-activated and activated human blood platelets. Biochim. Biophys. Acta. 1025:173-178.
24. Fink, B., and E. Bassenge. 1997. Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerytrilyl tetranitrate. J. Cardiovasc. Pharmacol. 30:831-836.
25. Weber, A.A., H. Strobach, and K. Schrör. 1993. Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur. J. Pharmacol. 247:29-37.
26. Skatchkov, M., L. Larina, A. Larin, N. Fink, and E. Bassenge. 1997. Urinary nitrotyrosine content as a marker of peroxynitrite-induced tolerance to organic nitrates. J. Cardiovasc. Pharmacol. Ther. 2:85-96.
27. Nunes, G.L., K. Robinson, A. Kalynych, S.B. King, D.S. Sgoutas, and B.C. Berk. 1997. Vitamins C and E inhibit O2-production in the pig coronary artery. Circulation. 96:3593-3601.
28. Beckman, J.S., H. Ischiropoulos, L. Zhu, M. van der Woerd, C. Smith, J. Chen, J. Harrison, J.C. Martin, and M. Tsai. 1992. Kinetics of superoxide dismutase-and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298:438-445.
29. Braughler, J.M. 1983. Soluble guanylate cyclase activation by nitric oxide and its reversal. Involvement of sulfhydryl group oxidation and reduction. Biochem. Pharmacol. 32:811-818.
30. Dikalov, S., B. Fink, O. Sommer, and E. Bassenge. 1998. Formation of reactive oxygen species in various vascular cells during nitroglycerin metabolism. J. Cardiovasc. Pharmacol. Ther. 3:1-11.
31. Toivanen, J.L. 1987. Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro. Prostaglandins Leukot. Med. 26:265-280.
32. Beetens, J.R., M.C. Coene, A. Veheyen, L. Zonnekeyn, and A.G. Herman. 1986. Vitamin C increases the prostacyclin production and decreases the vascular lesions in experimental atherosclerosis in rabbits. Prostaglandins. 32: 335-352.
33. Lehr, H.-A., B. Frei, and K.-E. Arfors. 1994. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc. Natl. Acad. Sci. USA. 91:7688-7692.
34. Retsky, K.L., M.W. Freeman, and B. Frei. 1993. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti-rather than prooxidant activity of vitamin C in the presence of transition metal ions. J. Biol. Chem. 268:1304-1309.
35. Lehr, H.A., A.S. Weyrich, R.K. Saetzler, A. Jurek, K.E. Arfors, G.A. Zimmerman, S.M. Prescott, and T.M. McIntyre. 1997. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J. Clin. Invest. 99:2358-2364.
36. Diaz, M.N., B. Frei, J.A. Vita, and J.F. Keaney, Jr. 1997. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337:408-416.
37. Booth, B.P., S. Jacob, J.A. Bauer, and H.L. Fung. 1996. Sustained anti-platelet properties of nitroglycerin during hemodynamic tolerance in rats. J. Cardiovasc. Pharmacol. 28:432-438.
38. Watanabe, H., M. Kakihana, S. Ohtsuka, and Y. Sugishita. 1996. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance. Circulation. 94:503-504.
39. Bassenge, E., N. Fink, and B. Fink. 1998. Effects of oxidant stress circumvented by antioxidants vitamin C or by β-blocker carvedilol metabolite BM 910228. Pfluegers Arch. Eur. J. Physiol. 435:R74.
40. Watanabe, H., M. Kakihana, S. Ohtsuka, and Y. Sugishita. 1997. The preventive effect of carvedilol on nitrate tolerance in patients with congestive heart failure. 19th Congr. Eur. Sue. Cardiol. Stockholm, Aug. 18:400.